Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Avrobio Inc reported $-25257000 in Operating Profit for its fiscal quarter ending in December of 2022.

Operating Profit Change
Akebia Therapeutics AKBA:US USD -24938000 18.59M
Alnylam Pharmaceuticals ALNY:US USD -149807000 38.81M
Bluebird Bio BLUE:US USD 8.44M 17M
Gilead Sciences GILD:US USD 1.7B 562M
Intercept Pharmaceuticals ICPT:US USD -31632000 13.61M
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
Karyopharm Therapeutics KPTI:US USD -30899000 2.97M
MacroGenics MGNX:US USD -38426000 50.41M
Pfizer PFE:US USD 6.79B 1.62B
Roche Holding ROG:VX CHF 5.93B 5.62B
Sangamo BioSciences SGMO:US USD 18.03M 73.43M
Sarepta Therapeutics SRPT:US USD -525417000 416.01M
Takeda 4502:JP JPY 88.56B 58.43B